Key facts
- This page summarizes Charles Everhardt's Form 4 filing for INNOVATIVE MEDTECH, INC. (IMTH).
- 3 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 23 Jun 2022, 16:01.
Charles Everhardt - 25 Mar 2021 Form 4 Insider Report for INNOVATIVE MEDTECH, INC. (IMTH)
- Reporting relationship
- Director, Chairman of the Board, 10%+ Owner
- Issuer ticker
- IMTH
- Reported as of
- 25 Mar 2021
- Net transaction value
- +$133,740
- Reporting owner signature
- /s/ Charles Everhardt
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Charles Everhardt filed Form 4 for INNOVATIVE MEDTECH, INC. (IMTH) on 23 Jun 2022.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: +$133,740.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
IMTH
transaction
Common Stock
Other
- Transaction value
- $123,001
- Shares
- +2,460,012
- Change %
- Price
- $0.0500*
- Shares after
- 2,460,012
- Date
- 25 Mar 2021
- Ownership
- By EF Trust, LLC
- Footnotes
- F1
IMTH
transaction
Series A Preferred Stock
Other
- Transaction value
- $5,027
- Shares
- +100,542
- Change %
- Price
- $0.0500*
- Shares after
- 100,542
- Date
- 25 Mar 2021
- Ownership
- By EF Trust, LLC
- Footnotes
- F2
IMTH
transaction
Common Stock
Other
- Transaction value
- $5,712
- Shares
- +114,244
- Change %
- +4.6%
- Price
- $0.0500*
- Shares after
- 2,574,256
- Date
- 25 Mar 2021
- Ownership
- By D&E Holdings 20, LLC
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
2,460,012 Common Shares were issued to EF Trust, LLC for its investment into the Company.
Footnote F2
100,542 Series A Preferred Shares were issued to EF Trust, LLC its investment into the Company.
Footnote F3
114,244 Common Shares were issued to D&E Holdings 20, LLC (of which Mr. Everhardt owns 50%) for its investment into the Company.